TY - JOUR
T1 - Differentiating effect of sodium butyrate on human hepatoma cell lines PLC/PRF/5, HCC‐M and HCC‐T
AU - Saito, Hidetsugu
AU - Morizane, Toshio
AU - Watanabe, Tetsu
AU - Kagawa, Tatehiro
AU - Miyaguchi, Shingo
AU - Kumagai, Naoki
AU - Tsuchiya, Masaharu
PY - 1991/5/10
Y1 - 1991/5/10
N2 - The in vitro effect of sodium butyrate (SB) on human hepatoma cell lines PLC/PRF/5, HCC‐M and HCC‐T was investigated. SB was added at the non‐toxic but cytostatic concentration of I mM. In all these cell lines, SB reduced cell proliferation and changed the morphology of the cells into a fibroblast‐like shape. In PLC/PRF/5, alpha‐fetoprotein production and c‐myc expression were inhibited. In contrast, gene expression of albumin, one of the normal liver‐cell products, Mid that of integrated hepatitis B virus genome, was increased. In HCC‐M and HCC‐T, c‐myc expression, which was enhanced In the naive state, was reduced. In HCC‐M, fos expression was inhibited but the expression of N‐ and K‐ras genes did not change. SB seemed to induce normal or mature properties of hepatocytes in human hepatoma cell lines.
AB - The in vitro effect of sodium butyrate (SB) on human hepatoma cell lines PLC/PRF/5, HCC‐M and HCC‐T was investigated. SB was added at the non‐toxic but cytostatic concentration of I mM. In all these cell lines, SB reduced cell proliferation and changed the morphology of the cells into a fibroblast‐like shape. In PLC/PRF/5, alpha‐fetoprotein production and c‐myc expression were inhibited. In contrast, gene expression of albumin, one of the normal liver‐cell products, Mid that of integrated hepatitis B virus genome, was increased. In HCC‐M and HCC‐T, c‐myc expression, which was enhanced In the naive state, was reduced. In HCC‐M, fos expression was inhibited but the expression of N‐ and K‐ras genes did not change. SB seemed to induce normal or mature properties of hepatocytes in human hepatoma cell lines.
UR - http://www.scopus.com/inward/record.url?scp=0025782613&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025782613&partnerID=8YFLogxK
U2 - 10.1002/ijc.2910480223
DO - 10.1002/ijc.2910480223
M3 - Article
C2 - 1708367
AN - SCOPUS:0025782613
SN - 0020-7136
VL - 48
SP - 291
EP - 296
JO - International Journal of Cancer
JF - International Journal of Cancer
IS - 2
ER -